Ocata Therapeutics Inc fka OCAT

[rocky301]

New location,

according to office space still retained by Sepracor(32,000 sq.ft) and what ACTC has(10,600 sq, ft), the two would occupy about 72% of total office space.

33 Locke Drive is a first class office and laboratory facility leased to Sepracor, a pharmaceutical company with annual sales in excess of 1.2 billion a total of 60,477 square feet on two levels. The building contains a mix of 60% first class office space and 40% lab space.

Dainippon Sumitomo Pharma would make a nice "sugar daddy" in an upcoming stem cell company..

In October 2009, Sepracor was acquired by Dainippon Sumitomo Pharma Co., Ltd., a top-ten listed pharmaceutical company based in Osaka, Japan, providing DSP access to Sepracor's fully integrated U.S.- and Canadian-based pharmaceutical infrastructure and pipeline platform.

Dainippon to buy U.S. drug firm Sepracor for $2.6 billion
http://www.reuters.com/article/idUSTRE58165U20090903